16:51
2026-06-25
letsdatascience.com
artificial-intelligence
Immunai Signs Discovery Deal With Boehringer Ingelheim
Immunai announced a discovery collaboration with Boehringer Ingelheim valued at up to $15 million through 2027. The partnership will apply Immunai's single-cell AI platform to identify T-cell targets โฆ